NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,868 | -32.6% | 5,921 | -30.9% | 0.00% | – |
| Q2 2023 | $63,645 | +85.9% | 8,566 | +73.4% | 0.00% | – |
| Q1 2023 | $34,234 | +52.4% | 4,940 | +126.1% | 0.00% | – |
| Q4 2022 | $22,462 | -54.2% | 2,185 | -17.7% | 0.00% | – |
| Q3 2022 | $49,000 | -58.1% | 2,654 | +16.9% | 0.00% | – |
| Q2 2022 | $117,000 | -24.0% | 2,270 | +9.0% | 0.00% | – |
| Q1 2022 | $154,000 | -27.0% | 2,083 | +41.8% | 0.00% | – |
| Q4 2021 | $211,000 | -49.6% | 1,469 | -27.5% | 0.00% | -100.0% |
| Q3 2021 | $419,000 | -6.7% | 2,025 | -4.4% | 0.00% | 0.0% |
| Q2 2021 | $449,000 | -48.9% | 2,118 | -56.3% | 0.00% | -50.0% |
| Q1 2021 | $879,000 | +17.5% | 4,848 | -27.7% | 0.00% | 0.0% |
| Q4 2020 | $748,000 | +21.6% | 6,706 | +18.2% | 0.00% | +100.0% |
| Q3 2020 | $615,000 | +101.6% | 5,674 | +55.2% | 0.00% | 0.0% |
| Q2 2020 | $305,000 | +6000.0% | 3,657 | +814.2% | 0.00% | – |
| Q1 2020 | $5,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |